Status:
COMPLETED
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Asia.
Eligibility Criteria
Inclusion
- Diabetic patients registered in the particular centre for more than 12 months
- Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit
- Patients willing to sign informed consent form
Exclusion
- Repetition of any patient as patients should not be included twice for any reason
- Unwilling to participate or unable to comply with protocol requirements
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
2370 Patients enrolled
Trial Details
Trial ID
NCT00887874
Start Date
May 1 2009
End Date
September 1 2009
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Taipei, Taiwan